Skip to main content
. Author manuscript; available in PMC: 2016 Aug 19.
Published in final edited form as: Clin Genet. 2013 Feb 21;84(6):546–551. doi: 10.1111/cge.12109

Table 1.

Migraine Prevalence and Relative Risk.

(A) Premutation Control P-value
Male
(n=112)		 Female
(n=203)		 Male
(n=71)		 Female
(n=83)
Age
(mean ± SD)
yrs		 59.94 ± 14.13 49.60± 13.73 53.88 ± 13.31 47.60 ± 15.21 Female: p = 0.278
Male: p = 0.004
(B) Premutation Control P-value
(RR, 95% CI)*
History of
Migraine
% (count/n)		 26.8%
(30/112)		 54.2%
(110/203)		 15.5%
(11/71)		 25.3%
(21/83)		 Combined: p < 0.001
(2.06, 1.49 – 2.86)
Male: p = 0.0406
(1.92, 1.03 – 3.57)
Female: p= 0.0001
(2.15, 1.46 – 3.18)
(C) Premutation with FXTAS Premutation without FXTAS
Male
(n=75)		 Female
(n=40)		 Male
(n=37)		 Female
(n=163)
History of
Migraine
% (count/n)		 26.7%
(20/75)		 60.0%
(24/40)		 27.0%
(10/37)		 52.8%
(86/163)		 Combined: p = 0.046
(1.40, 1.01– 1.96)
Male: p = 0.1675
(1.75, 0.79 – 3.88)
Female: p = 0.1118
(1.34, 0.94 – 1.91)
*

95% confidence interval (CI) and p-values for relative risk (RR) of premutation relative to control and premutation with FXTAS relative to premutation without FXTAS, both adjusted for age and gender.